ProFunds Pharmaceuticals UltraSector Fund

Scorecard
2 / 5 Stars
Lipper
4 3 4 3 1
Zacks Investment Research
3 (Hold)
Standard & Poor's
4 / 5 Stars
TheStreet.com
A+ (Buy)